Atlas FDA

VNS THERAPY SYSTEM LEADS

FDA premarket approval P970003/S161 · decided 2013-05-03

Approval details

PMA number
P970003
Supplement
S161
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
VNS THERAPY SYSTEM LEADS
Generic name
Stimulator, autonomic nerve, implanted (depression)
Applicant
LivaNova USA, Inc.
Date received
2013-04-05
Decision date
2013-05-03
Days to decision
28 days
Decision code
OK30
Product code
MUZ
Advisory committee
Neurology
Expedited review
No
Location
Houston, TX
Statement
ADDITION OF AN ALTERNATIVE ELASTOMER MIXING PROCESS FOR VARIOUS LEAD ASSEMBLY MODELS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Venous Return Cannulae (K250937)LivaNova USA, Inc.2026-03-11
RAP Femoral Venous Cannulae (K250283)LivaNova USA, Inc.2025-07-10
SMARxT Tubing and Connectors (K233702)LivaNova USA, Inc.2024-08-08